Member Info for Lottohopes

Evening folks :) I thought I d recap my understanding of the situation. Let’s leave the mechanics of the board selling, out of it. Its too messy, too emotive and speculative.

P2F has been colloborating with Prof Bob Stevens for the last few years on other projects. They decided during COVID to work on a face mask with nano copper in it. Prof Stevens brought his expertise in printed electronics and P2F brought their nano tech+ chemistry background. The mask was designed using a grant from Innovate UKRI UK and the nano tech behind it has applied for a patent. It took the last 8 months to develop.

Other patents held by P2F include one for a nano reactor to produce particles, nano tech for producing fertiliser material (crop fortification).

We know the machine to produce the masks can run UPTO 5 m masks a month. I don’t expect it to start at full capacity, given some tweaking is inevitably needed in manufacturing. We have been told it is delayed and delivery expected in the UK (coming from Spain) by Mid December. We are also told it will be commissioned and producing masks by Jan 2021. These time frames are just 3 weeks away.

An RNS also told us that Volz will produce masks with P2F brand for us to sell, masks with Volz own brand too. We are also told that our nano tech fabric is easily scalable (we can make 100s of meters of it within minutes by printing an ink with nano copper, on to the melt blown fabric). MB fabric is THE supply pinch point in making these masks-we have secured a supply from Europe (Volz). Only one co makes this fabric in the UK-Don and Low. So I expect we will sell our nano fabric to other mask makers, here in the UK and in the EU.

Few days ago, we discovered that FortOaks CEO Alex Vergopoulos has been added to the P2F board (NOT RMS board) as an executive director. Presumably he will drive the sales effort from his LinkedIn description. Alex runs a company FortOaks (18m annual rev last year) with several threads-till rolls, labels, PPE-supply of raw material upto finished product. Co website suggests they are very experienced in building a real business and are on the verge of explosive growth (80% growth year on year last four years in the till roll/label segment) and keen to capitalise on PPE-not just masks but ALL PPE. They have existing relationships with several supermarkets ASDA, Morrisons etc and other independents so this will give us inroads into retail imho. The other interesting part for me is they acquired 49% of Ticketmedia and Purplepaper. Purplepaper has contacts and custom within the health care sector. And Jeremy Burbidge the director of these two outfits is also a director of Flextronix.

My own thinking is that there is a bigger plan around these movements and it will be revealed when the chess pieces are firmly in place. Until then we are playing blind and so the sensible thing to do for me is to just hold patiently. Of course its easier to do when you are above water. All imho. Good l

Parsley: this is a unique product. All other antiviral face masks are face coverings, and do not have a medical device certification.

The anti viral properties of Cu Ag Zn etc are well studied for decades. Plenty of “lab” masks including surgical masks that kill the virus. The main challenge was commercialising the idea, and making it scalable: in volume, at speed and at a price point that works for a disposable mask. P2F has done it imho. As always I m on the look out for any competition or similar products on the market. Both here in the UK and other markets. I haven’t found a like for like at same price point and universally available, yet. Of course some one may develop a similar product elsewhere. That won’t impinge our market, because I believe there’s space for plenty of competition just like the vaccine. Good luck all

I think the question to ask is: would independent share holders have voted yes, to the share issue and the P2F take over, had they known that BRH would almost immediately sell out its large stake? The answer is no imho. Why would they vote to have a near 50% dilution knowing there are related parties on both sides of the transaction, who can do exactly what they did? In my eyes, this is why people like S Jones (previous TR1 holder) sold out unceremoniously. He was a big believer in GyroMetric and the tech, being an engineer himself.

The P2F circular unequivocally mentioned that BRH would hold its RMS shares for the a foreseeable future. Integrity is doing what you say you will. And does integrity matter in business? The people shouting that it makes good business sense for a large holder to sell into a rally are either defective morally or intentionally blind siding this aspect of conflict of interest, thinking making money is all that matters. I am the first to point out the huge cash that directors ploughed into this near dead horse from December 2017 and their efforts over 3 years to reinvigorate this company. They richly deserve to make that cash back manifold, but the timing and pace has been very disappointing. (Just to be clear, I m not a bitter loser, I haven't lost any money here, I was in from sub 1p, and frankly don’t give a **** if it goes back to 1p. Making money is a matter of fate imho). There is often a thin gap between what is legally correct vs what is morally correct. Especially when hundreds (potentially thousands) of ordinary investors have lost their nerve, lost hard earned money in the games played over the last few weeks. There is a cost to this in a karmic sense, and-it is an inescapable metaphysical law imho.

Moving forwards, I would urge RMS investors NOT to sell based merely on the righteous indignation that one feels. I do think there is value being built brick by brick. We are not being informed of that process and hence we will have to join the dots, use our intuition and listen to our instincts. It will all become clear as time goes by. December or January, masks aren’t going anywhere. Neither is farming because a growing population needs feeding. Or turbines or manufacturing. And I love oranges. Good luck all

Good luck Rossannan. Having been in this share since 2017, I can empathise with what I describe as a fatigue of hope. The news flow has been disappointing and the copper market did conspire against us, at least twice. I do agree that the picture is kept opaque, somewhat intentionally I imagine. Plenty of drilling has taken place, now for over 12 months (I recollect it commenced in Nov 2019).

Sometimes companies want the share price where it is, or even lower whilst the mechanics are worked out. To me this is now a curious and somewhat unpalatable fact of investing, especially pertinent when directors are looking for more; it took me some time to get my head round. There is work ongoing to create “value” and at some point that value will be revealed to market. All the best again.

Most welcome folks! We deserve some positive news here with the rollercoaster of the last few weeks. I think there are plenty of things happening behind the scenes but until it’s all lined up, it remains speculation and open to doubt. Good luck all

“Fortoak produces till rolls and labels for retail stores Tesco, Morrisons, Asda, Coop as well as many other non-food Retailers.” `From their website. That’s big supermarkets covered. So I m hoping this opens some doors into retail side too.

My guess is that this is an appointment to a sub, so doesn’t need RNS. Could be wrong. Would be great if he’s been accumulating RMS shares, who knows. I like the fact the team is being strengthened.

Guess what I found on Linkedin; a new appointment to the P2F board. Alex Vergopoulis appointed “Executive Director”. Alex heads Fortoak a UK based PPE supplier (they do several other things)

https://fortoak.co.uk/

https://www.linkedin.com/in/alex-vergopoulos-6185329/?originalSubdomain=uk

“Responsible for Sales, Production and Logistics at Pharm2Farm Ltd which is a wholly owned subsidiary of Remote Monitored Systems PLC. The company has developed and patented nanotech manufacturing and applications in conjunction with Nottingham Trent University. Its initial sales strategy is with two rapidly growing market sectors - Antiviral PPE and AgriTech.”

It’s nice to see the team being strengthened on the commercial side. Note he mentions PPE and AgriTech as the main foci for now.

Partypooper: your statements suggest that FFP3 masks are more effective than FFP2/surgical masks at reducing Covid risk. The evidence says they are only as effective. Cost is king yes, so if they are only as effective, then why would govt pursue FFP3 when the cheaper variants are available? I believe the P2F mask sits nicely in between.

https://www.cebm.net/covid-19/what-is-the-efficacy-of-standard-face-masks-compared-to-respirator-masks-in-preventing-covid-type-respiratory-illnesses-in-primary-care-staff/

This article also makes a key statement pertinent to our masks. That viral particles deposited on surfaces can become air borne again.

Exact statement: “This finding is relevant because it suggests that deposited particulates may become resuspended i.e. airborne, when disturbed.”

My apologies I have now blocked you and do not intend to respond to any messages. Good luck anyways. You must follow your own reading as I do mine.

Partypooper: Majority of NHS and social care staff wear surgical masks, not FFP3 masks. There is a global shortage of FFP3 and their prices are steeply higher than the less effective variants. If within one metre, then gloves, aprons and face screens are added to the surgical masks. Only higher risk aerosol generating procedures-surgical, ENT, dentistry etc OR if patient is known/suspected to have Covid does FFP3 come into play.

The FFP3 respirators with valves are bit points less imo for COVID. They open the valve passively to allow effortless exhalation(otherwise you would have a lot of humidity trying to breathe out through the valve). What that means is that clinicians are protected from patients/careers. However an infectious asyptomatic clinician is still breathing out air with the virus in it. And the valve is merely opening to let that air out. I know many will not believe things posted here-so hers the link to the ENT guidelines, telling clinicians explicitly NOT to wear valved masks in close patient interaction. (Second link below)

https://www.rdash.nhs.uk/wp-content/uploads/2017/08/appendix-47-surgical-face-mask-ffp3.pdf

https://www.entuk.org/sites/default/files/BAOMS%20ENT%20PPE%20-%20Avoid%20Using%20FFP3%20masks%20with%20valves%20for%20close%20patient%20interactions%20May%202020.pdf

So where am I going with all this? That the default position is cheap and cheerful surgical masks, for the NHS and social care. Whether that’s P2F or otherwise. Look around you and see what people are wearing in GP surgeries, clinics, wards and waiting areas. It isn’t FFP3. Because there is a global shortage and prices have rocketed.

And amongst the surgical masks, the antiviral coating has a clear advantage. Thats my considered opinion. Will the mask sell at £1 for the NHS? No, I think it will be cheaper. Will the NHS go for masks that are say 50/60/70p, if they last a full shift, compared to the cheaper variants that are say 10p and need changing every 1-2 hours? I d say this decision will be up to each trust, but if one employer goes for it and another doesn’t, would unions/clinicians/relatives and patients stand for it? I ll let you answer that.

These are purchasing decisions concerning infection, not just viral infection, but the mask filters and kills all bacteria too. How many hospital acquired infections may be respiratory but NON Covid? Answer: a great majority. The infamous MRSA and Pseudomonas to name two cause respiratory infection and are air borne. So will any surgical mask help reduce these other infections? My common sense tells me of course they will. And by extension, a mask that kills the virus within its layer will be more effective. All in my opinion only. Please DYOR.

Forget the noise. Options tend to be given at a price level that companies consider below what’s achievable. Plenty of news ahead. We are in a copper gold bull market and ramping up. All costs to develop the ore bodies, underground mining infrastructure were front loaded. Gati and the other directors have supported this for over 12 months, through grim times. They want their pound. They invested millions higher up (Gati bought in at 16p and 12.5p so his average is quite a bit higher even after the 3p placing done during Covid) Please DYOR.

I wanted to restore the “balance” as regards comments made about the board, and their so called greed. The same board ie TB, PR and Nigel (now gone from board) invested nearly £1m of their cash into Aero (PR was in Aero before TB/NB). Trevor and Nigel rescued the shell that Aero had become (see RNSs 2017 December) and put in huge amounts of cash. Admittedly some of the ventures didn’t work out (Geocurve for ex), but they swiftly severed any liabilities.

So in essence, having invested heavily for nearly 3 years, they are entitled to encashing a slice, indeed richly deserve it. No one invests money in business like charity. But we are shocked to find they sold out entirely. What if there is a deeper story behind this, rather than the simple greed that us clueless PIs propose?

PI sentiment is fickle, it relies only on today’s share price. Our vision is mostly myopic. If the share register is getting institutionalised, they would want in cheap, not at 4/5/6p. And the mechanics over last 2 weeks suggests a big buyer. A big holder or two would provide stability in sp and reassurance to PIs, especially newer investors. As a co grows, it actually sheds it’s early investors in favour of more mature holders. All imho only. Please DYOR.

Badsterman: you are correct, GyroMetric has yet to find application in the wind turbine industry. It’s been endorsed as a “game changer” by ORE (offshore research Blyth). The explicit purpose of ORE is to develop tech, research wind energy and help SMEs grow in terms of wind related opportunities. I m pleased there is some discussion away from Covid and masks, there’s more to RMS. It’s original market was marine industry: on ship drives. Given it has proven reliability in harsh marine environments, turbines became the natural next step. The plans to commercialise there have hit delays, given major turbine makers (we have 3, GE, Siemens Gamesa and MHI Vestas) move slowly, and latterly Covid.

We have been selling our units via Vulkan (German giant in couplings) and a big Turkish Co Gani Gemi who supplies shipping and rail. Last accounts mentioned £57k in Gyro sales. So it is early days but I believe the P2F growth will provide much needed capital to grow our other subsidiaries.

Of course there are numerous industries in which GyroMetric tech finds application, essentially any industry where there is axial rotation. Energy, manufacturing, automobile etc etc. There were trials lined up with key players such as Tarmac (huge reach given number of factories/plants globally), Clarke Energy (distributed Energy ie remote discrete power units often unmanned but critical to support local energy needs where reliability is key; energy is moving away from centralised grids to decentralised). There are others too but these haven’t been announced. John Richardson was in senior roles in Siemens for decades, so I m hopeful he can get us moving. Of course things take time and Covid has disrupted site visits, installations. All imho only.

There are existing issued patents for
1. The Nano particle producing SDR (spinning disc reactor) technology method. The method creates nano particles at room temperature and room pressure, thereby bioavailability etc not affected. Easily scalable and at affordable costs.

https://uspto.report/patent/app/20180280910

2. The method of producing nano particles incorporated within organic/amino acid solutions, that plants can easily absorb. The nano sized particles of silica, iron etc in the “Nsitu” range, are perfect for plants. Natureintended for nutrient particles that get absorbed to be “nano” sized. Hence pores on root systems, pores on leaves are all “nano” sized. Using nano supplements that get absorbed at higher percentages means lower fertiliser use and reduced run off/toxic damage to environment from processes such as eutrophication. (Over 75% of fertiliser ends up in water bodies/environment rather than the plants it was intended for, essentially farmers overfertilise given low absorption and its destroying the delicate balance)

https://patents.google.com/patent/EP2825515A2/en

https://patents.justia.com/patent/20150027050

3. Patent applied for the newest application ie Cu nano particles incorporated fabric, is pending. (The pending ref number is mentioned on P2F website).

Dr G Cave and his team have decades of post doctoral experience and they have published extensively on various subjects which are the sectors in which P2F is trying to commercialise. This is not a flash in the pan mask that came out after a few days work or a gimmick.

Gareth collaborated with Prof Bob Stevens (of Flextronix) on the mask, this is mentioned in the UKRI/Innovate Project page. Please take a look at Prof Stevens background-he is a Prof of smart materials at NTU. P2F provided the nano particle knowledge, Flextronix had the flexible electronics and printing background. They have worked together on fabric/mask composition before on another INNOVATE project, as GC eluded to in the interview.

Appearing on numerous TV channels, news outlets, being endorsed by the Nottingham Trent Uni would just not happen imho if it was an elaborate hoax or fraudulent. His career would be destroyed as well as his academic standing, not to mention the market would never touch any of his ventures, with a barge pole again.

If any of the points mentioned in that sharetalk interview were contentious or indeed plain misleading, the parent company would have had the legal obligation to RNS the change/amendment. They haven’t, which means its all happening behind the scenes. This is my humble opinion. I m not going to suggest pie in the sky figures of 10p, 20p etc. Obviously these numbers are possible if growth comes from multiple avenues. I have detested the recent spikes, and would rather have a sustainable “business” with revenue and say 3/4/5p. And some cash that can be well utilised to leverage growth in GyroMetric, Cloudveil and other ideas within P2F por

Broker note mentioned $1.75 as all in cost/lb, with further efficiencies likely. Capstone numbers for underground production were much lower. A large amount of capital has been spent over last 12 months, in anticipation of ramp up. Every cent rise in copper goes straight to profit line. DYOR.

Evening folks :) I’ve had a bit of time to digest the days events and the morning RNS. It was very plain, uninspiring and quite down beat. So why would such an RNS be put out? The board has sold, so they have no immediate interest in egging the sp higher. But why release negative news (delays always get interpreted badly), that too with ZERO mention of any other developments such as Volz, or other aspects of P2F or indeed some small update on another subsidiary to sweeten the pill? Only one intention: to flatten or deflate sentiment and sp. If this board which is known for its Machiavellian games wants sp depressed, then it’s a buy imho. I know this sounds perverse and of course some will accuse me of trying to shore up sentiment, but frankly I don’t care. This is my humble perspective. There is development behind the scenes and a big buyer or two. 800m shares cant disappear into just PI pockets.

On the flip side, if 4/5/6 p were mere flash in the pan prices which we never see again here, that itself would add credibility to the P&D story which I m certain the FCA would be very interested in hearing about. If dozens of angry PIs raise concerns, they will have to look into it. Time will tell. Entirely possible a big buyer or two lined up and the board decided it was opportune to sell into that appetite, and indeed help reduce their average ;). If Volz is not our partner, the co is legally obliged to clear up the misinformation. These are just my thoughts and I could be completely off mark. Please follow your own instinct and try not to stare at sp all day. Good luck all

Fact: the certifications that manufacturers have for a fabric can be used by anyone who purchases it. So using Volz fabric will mean no delays in certification as far filtration is concerned.

The patent reference posted was a big positive in my mind. There is a disconnect between board aspiration and P2F, it appears. Please DYOR.

Shardster: sound advice. Unfortunately many will rush for the exit. The language in the RNS is very matter of fact and uninspiring. It isn’t laced with any optimism or updates on other threads such as Volz contract, again feels as though price is being brought down. But it’s for individuals to judge and act on. Fear always creates more ripples than hope or greed. It looks like games being played. Please DYOR.

Thanks for posting Novice20. Interesting updated page on Pharm2farm.

There is a short delay in granted patents being published. Today the register goes up to GB2016243, so I ll check in couple of weeks and post when I find it.

I think it wasn’t just the cash call that prompted the drop from 33% to 11%. I imagine there were issues within the agreement signed, which meant we owed significant amounts from payment schedule. I don’t confess to understanding it all, but at the end of the day, we own an 11% economic interest in a mine mill complex, which is being rapidly ramped up, in a full on copper gold silver bull market. Historic production has been up to 20,000 tonnes of copper, 40kOz of gold annually. And our market cap is some 3m. There is plenty of news ahead. Debts include the 2.9m loan from the CEO. This is nearly counterbalanced by the money that Minto exp will return to Pere in 2022.

What I always remind myself is that there were big pocketed investors who participated in both raises (at 16p new money and then 12.5p post consolidation). This included Gati in both raises and hence I fully well expect he will do his best to return value to share holders, given it serves his own interests too.

The third concentrate shipment was due to leave for Japan imminently ie before November end (a word solgers understand too well lol).

Minto mine website states they are shortly going to 3 weeks on and 1 week off with the milling (this signals increase in mining as ore supply was the bottle neck with opening up of new area).

Grade of ore should improve given we are now entering the ore body from periphery.

We should see the first two 5m payments made by Minto exp within next six months (first 5m to capstone when Minto has been running at 60% “steady state” capacity, second 5m payment when Cu is 3/lb for two consequetive quarters.)

Then there’s mine life being extended which imho is a given. Bonuses would be new mineralisation areas in our land packages, renegotiating of the Wheaton Gold stream (it must be near its 11koz limit). We will also see a renewal of our Sumitomo agreement. All above imho only.